Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 2, 2006, Pages 359-363

  Lee, Jennifer S ^a,b   John, Esther M ^c   McGuire, Valerie ^a   Felberg, Anna ^a   Ostrow, Kimberly L ^d   DiCioccio, Richard A ^d   Li, Frederick P ^e   Miron, Alexander ^e   West, Dee W ^a,c   Whittemore, Alice S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NORTHERN CALIFORNIA CANCER CENTER   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RISK; CORRELATION ANALYSIS; DNA MODIFICATION; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; RELATIVE; RISK ASSESSMENT; UNITED STATES;

ADULT; AGE OF ONSET; AGED; BREAST NEOPLASMS; EXONS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; RISK;

EID: 33644757518     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0687     Document Type: Article

References (26)

1. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71:800-9.
2. Colditz GA, Willett WC, Hunter DJ, et al. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. JAMA 1993; 270:338-43.
3. Schildkraut JM, Thompson WD. Relationship of epithelial ovarian cancer to other malignancies within families. Genet Epidemiol 1988;5:355-67.
4. Schildkraut JM, Risch N, Thompson WD. Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet 1989;45:521-9.
5. Bergfeldt K, Rydh B, Granath F, et al. Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet 2002;360:891-4.
6. Dite GS, Jenkins MA, Southey MC, et al. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 2003; 95:448-57.
7. Loman N, Bladstrom A, Johannsson O, Borg A, Olsson H. Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res 2003;5:R175-86.
8. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet 2001;358:1389-99.
9. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
10. Claus EB, Schildkraut J, Iversen ES, Berry D, Parmigiani G. Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst 1998;90:1824-9.
11. John EM, Hopper JL, Beck JC, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6:R375-89.
12. Kalbfleisch JD, Lawless JF. Likelihood analysis of multi-state models for disease incidence and mortality. Stat Med 1988;7:149-60.
13. Whittemore AS, Halpern J. Multi-stage sampling in genetic epidemiology. Stat Med 1997;16:153-67.
14. McGuire V, Felberg A, Mills M, et al. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am J Epidemiol 2004;160:613-8.
15. Lum A, Le Marchand L. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol Biomarkers Prev 1998;7:719-24.
16. Miller SA, Dukes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
17. Van Orsouw NJ, Dhanda RK, Elhaji Y, et al. A highly accurate, low cost test for BRCA1 mutations. J Med Genet 1999;36:747-53.
18. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-9.
19. DiCioccio RA, Piver MS. A polymorphism in intron 2 of the TP53 gene. Clin Genet 1996;50:108-9.
20. Tworek H, Peng R, Fetzer S, et al. Mutation Analysis of BRCA1, TP53, and KRAS in ovarian and pelvic related tumors. Cancer Genet Cytogenet 1998; 112:105-18.
21. Holford TR. The analysis of rates and of survivorship using log-linear models. Biometrics 1980;36:299-305.
22. Laird N, Olivier D. Covariance analysis of censored survival data using loglinear analysis techniques. J Am Stat Assoc 1981;76:231-40.
23. Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med 2003;24:190-8.
24. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York: Oxford University Press; 1993.
25. Eng C, Brody LC, Wagner TMU, et al. on behalf of the Steering Committee of the Breast Cancer Information Core (BIC) Consortium. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 2001;38:824-33.
26. Gross E, Arnold N, Goette J, Schwarz-Boeger U, Kiechle M. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 1999;105:72-8.